Success Story: NIW Approval for a Ph.D. Candidate from China in 4 months, Despite Receiving an RFE
Client’s Testimonial:
“Everything is good, but promptness in response can be improved.”
On January 9th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. candidate in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Ph.D. candidate
Country of Origin: China
State of Residence at the Time of Filing: Georgia
Approval Notice Date: January 9th, 2025
Processing Time: 4 months, 26 days
Case Summary:
Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling EB-2 National Interest Waiver (NIW) petition for a Ph.D. Candidate from China who holds a B.S. in Biomedical Engineering.
As an expert in biomedical engineering, the client’s proposed endeavor is to continue conducting research and developing novel strategies and therapies to target various diseases, including cancer, autoimmune diseases, and infectious diseases, to significantly enhance the adoption of biotechnology for cancer therapy and vaccine development.
We demonstrated that the client’s research addresses critical national needs in public health, particularly cancer treatment, affecting approximately 2 million Americans diagnosed annually. The work directly supports U.S. leadership in critical and emerging technologies as identified by the National Science and Technology Council.
To strengthen the petition, we emphasized the client’s exceptional credentials:
- Publication: 9 peer-reviewed journal articles, 1 peer-reviewed conference article, and 2 filed patents
- Citation: 1,956 citations
- Major funding: The National Institutes of Health (NIH), Army Research Office (ARO), Defense Advanced Research Projects Agency (DARPA), National Cancer Institute (NCI), Wellcome Leap HOPE program, National Institute of Allergy and Infectious Diseases (NIAID), the Innovative Molecular Analysis Technology program of the NCI, Department of Defense (DOD), Juvenile Diabetes Research Foundation (JDRF), the Hartwell Foundation, the Novo Nordisk Company, and the Terry Fox Research Institute
The petition included two strong recommendation letters from experts, with one professor emphasizing:
“Considering the impact of [Client]’s research and [Client]’s incredible work ethic, I am confident [Client] will make exceptional contributions to science in the United States.”
We are pleased to share that following our thorough RFE response, the NIW petition was approved in just under 5 months. It has been an honor to support this extraordinarily talented researcher, and we extend our sincere best wishes for continued success in advancing discoveries that will benefit public health.

